Hereditary Breast and Ovarian Cancer Syndrome: all 62 studies
Page 1 of 1. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.
- PreCharge: An Innovative Digital Program to Increase Coping, Resilience, and Health Care Engagement Among Cancer PrevivorsNot yet recruitingNCT07936682Not applicable
- Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic VariantsNot yet recruitingNCT07764744Not applicable
- Evaluation of Well Being and Patient Reported Outcomes After Robotic Single-port Nipple Sparing Mastectomy and Implant ReconstructionNot yet recruitingNCT07236359Not applicable
- Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer ProbandsRecruitingNCT07039552
- Patient Centered Clinical Decision Support for Hereditary Cancer SyndromesEnrolling by invitationNCT06914726Not applicable
- The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRIRecruitingNCT06892275Not applicable
- CfDNA in Hereditary And High-risk Malignancies 2RecruitingNCT06726642
- Identifying and Caring for Individuals With Inherited Cancer SyndromeRecruitingNCT04494945Not applicable
- Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in SwitzerlandRecruitingNCT03124212
- Familial Investigations of Childhood Cancer PredispositionRecruitingNCT03050268
- Efficacy of Lifestyle Intervention in BRCA1/2 Mutation CarriersRecruitingNCT02516540Not applicable
- Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier RegistryRecruitingNCT02302742
- Specimen and Data Study for Ovarian Cancer Early Detection and PreventionRecruitingNCT00005095
- Pediatric Reporting of Adult-Onset Genomic ResultsCompletedNCT03832985Early Phase 1Results posted
- Cancer Health Assessments Reaching ManyCompletedNCT03426878Not applicableResults posted
- A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate CancerTerminatedNCT02203513Phase 2Results posted
- Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both OvariesCompletedNCT00305695Phase 2Results posted
- Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE StudyCompletedNCT06534424Not applicable
- Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer PredispositionCompletedNCT05721326Not applicable
- Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) InterventionActive, not recruitingNCT05677048Not applicable
- Study of Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2 Mutation Carriers (BRCA-HRT)Status unknownNCT05409222
- Nutritional Intervention and DNA Damage of Patients With HBOCCompletedNCT05306002Not applicable
- CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and TestingCompletedNCT05130606Not applicable
- Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk DetectionTerminatedNCT04668521
- Enhance the Use of Genetic Counseling and Testing in LatinasCompletedNCT04544501Not applicable
- Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch SyndromeTerminatedNCT04508764Not applicable
- Scalable Communication Modalities for Returning Genetic Research ResultsCompletedNCT04407611Not applicable
- Cell-free DNA in Hereditary And High-Risk Malignancies 1Active, not recruitingNCT04261972
- Direct Information to At-risk RelativesActive, not recruitingNCT04197856Not applicable
- Evaluation of the Adhesion to the GENEPY NetworkStatus unknownNCT03979612
- Tissue Expansion in Breast Reconstruction Without DrainsCompletedNCT03784859
- Testing an Intelligent Tutoring System to Enhance Genetic Risk AssessmentCompletedNCT03511690Not applicable
- Genetics and Heart Health After Cancer TherapyCompletedNCT03510689
- Genetic Risk: Whether, When, and How to Tell AdolescentsCompletedNCT03421327
- Risk-Reducing Surgeries for Hereditary Ovarian CancerStatus unknownNCT03294343Not applicable
- Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.Active, not recruitingNCT03246841Not applicable
- Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation CarriersStatus unknownNCT03162276Phase 3
- Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian CancerCompletedNCT03075540Not applicable
- Inherited Susceptible Genes Among Epithelial Ovarian CancerStatus unknownNCT03015376
- Neoadjuvant Carboplatin in Triple Negative Breast CancerCompletedNCT02978495Phase 2
- Statewide Communication to Reach Diverse Low Income WomenCompletedNCT02956681Not applicable
- Identification and Referral of Women at Risk for Hereditary Breast/Ovarian CancerCompletedNCT02786147
- Surgery in Preventing Ovarian Cancer in Patients With Genetic MutationsActive, not recruitingNCT02760849Not applicable
- Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC RiskTerminatedNCT02705924Not applicable
- Women at Risk of Breast Cancer and OLFM4Active, not recruitingNCT02653105Not applicable
- Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot StudyCompletedNCT02562170Phase 4
- Genetic Counseling for Breast Cancer Survivors (GC for BC)CompletedNCT02451735Not applicable
- Cancer Genetics Hereditary Cancer Panel TestingCompletedNCT02324062
- Feasibility of Lifestyle Intervention in BRCA1/2 Mutation CarriersCompletedNCT02087592Not applicable
- Radical Fimbriectomy for Young BRCA Mutation CarriersActive, not recruitingNCT01608074Not applicable
- Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199WithdrawnNCT01445275
- Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation CarriersCompletedNCT01367639Phase 2
- Search Allelic Imbalance of Expression of BRCA Genes in Hereditary Risk of Breast and/or Ovarian CancerCompletedNCT01333748Phase 2
- Outcomes After Perforator Flap Reconstruction for Breast Reconstruction and/or Lymphedema TreatmentStatus unknownNCT01273909
- Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous TherapyCompletedNCT00892736Phase 1
- Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC)CompletedNCT00829959
- Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age ChildrenCompletedNCT00685256Phase 3
- Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 MutationCompletedNCT00673335Phase 3
- Telemedicine vs. Face-to-Face Cancer Genetic CounselingCompletedNCT00609505Not applicable
- Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid CancerCompletedNCT00535119Phase 1
- Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast CancerCompletedNCT00321633Phase 2
- Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast CancerCompletedNCT00253539Phase 2